Open AccessUsing Implementation Science to Better Integrate Novel Long-Acting Injectable Therapy Into Routine HIV Care
Author(s) -
Maggie Czarnogorski
Publication year - 2019
Publication title -
journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.162
H-Index - 157
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/qai.0000000000002218
Subject(s) - implementation research , clinical trial , general partnership , medicine , human immunodeficiency virus (hiv) , health care , translational science , process management , business , nursing , political science , psychological intervention , family medicine , finance , pathology , law
The key to maximizing the value of implementation science data is to get the learnings early. A critical contributor to early clinical research data is the biopharmaceutical industry. In partnership with the implementation research community, industry has an opportunity to play a major role to increase the value of implementation research data through earlier integration of implementation questions in the development continuum.